Trial Profile
A phase III clinical trial of dasiprotimut T in patients with follicular lymphoma.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Aug 2012
Price :
$35
*
At a glance
- Drugs Dasiprotimut T (Primary)
- Indications Follicular lymphoma
- Focus Registrational; Therapeutic Use
- 16 Aug 2012 New trial record